Therefore this study cannot provide a definitive conclusion regarding the use of anti-estrogens in lung cancer, however, it suggests that ER expression may be able to predict efficacy of hormonal therapies and warrants validation in larger trials. The gene discussed is ESR1; the disease is lung carcinoma.